Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Cost-Effectiveness of Ibrutinib As First-Line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran
Meysam Seyedifar
Meysam Seyedifar

Assistant Professor of Pharmacoeconomics and Pharmaceutical Administration

Pharmaceutical Management & Economics Research Center

Tehran University of Medical Sciences

All Documents